Extrait

Raltegravir is the first of a new antiretroviral class. A better profile of metabolic toxicity is expected. In order to better define its effects, without interference with other drugs, a study on healthy volunteers is warranted.

Critère d'inclusion

• Healthy Volunteers

Liens

• ictrp
• nct